FPT-SOFTWARE
5.8.2024 09:31:33 CEST | Business Wire | Press release
Global technology company FPT Software, a subsidiary of FPT Corporation, and KITZ Corporation, a world-leading manufacturer of industrial valves and fluid control products, recently signed a strategic partnership agreement. The collaboration leverages FPT Software’s scalable workforce and robust expertise to accelerate the digital transformation initiatives across KITZ’s manufacturing and business operations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240804936324/en/
The signing ceremony took place in Tokyo, Japan, with KITZ Corporation CEO Makoto Kohno, FPT Corporation EVP and FPT Software CEO Pham Minh Tuan, and senior executives from both sides. (Photo: Business Wire)
Under the agreement, FPT Software will provide digital solutions to enhance KITZ’s product development and design, global supply chain, maintenance services, and sales and marketing activities. FPT Software will also enhance KITZ’s IT infrastructure through cutting-edge, AI-infused solutions to facilitate its operation and manufacturing with greater precision, efficiency, and safety.
“Driving agility, scalability, and enhanced productivity for our clients has always been FPT Software’s priority. With two decades of experience accompanying industry giants in Japan, a diversified delivery network, and a high-quality workforce globally, we are confident to help KITZ streamline operations and improve time-to-market to stay ahead of the rapidly changing manufacturing landscape,” said Pham Minh Tuan, FPT Corporation Executive Vice President and FPT Software Chief Executive Officer.
"I believe that forming a strategic partnership with FPT, a company that provides the latest technologies and services in the digital field, is a significant step forward. We are currently constructing a factory in Vinh Phuc Province, Vietnam, to manufacture and sell stainless steel valves, which are expected to be in high demand in the future, and a factory to produce high-purity gas valves for the semiconductor equipment market. In Vietnam, which is experiencing remarkable growth, we will continue to provide products and services tailored to our customers' markets and regions by partnering with FPT, a global company that has been at the forefront of DX initiatives for many companies,” said Makoto Kohno, KITZ Corporation Chief Executive Officer.
With nearly 20 years in Japan, FPT Software has become one of the largest foreign technology firms in terms of workforce, with 3,500 employees across 17 local offices and innovation hubs, as well as 15,000 global employees dedicated to the Japanese market. The company has provided services and solutions to over 450 clients worldwide, supporting their digital transformation through strategic consulting services and advanced technological solutions such as AI, machine learning, and cloud computing. The IT firm also plays a significant role in promoting technology cooperation and development between Vietnam and Japan, notably an active member of the Japan Business Federation (Keidanren) and the chair of the Vietnam Association of Digital Transformation in Japan (VADX Japan).
Manufacturing is among FPT Software's key domains. It provides comprehensive strategies and execution processes for digital factories on a global scale, leveraging its deep expertise and wide skills network to deliver complex end-to-end projects that enhance manufacturing operations. These proven competencies and success place FPT Software as a leader and disruptor in manufacturing services by IDC MarketScape and HFS Horizons.
About FPT Software
FPT Software, a subsidiary of FPT Corporation, is a global technology and IT services provider headquartered in Vietnam, with $1 billion in revenue (2023) and over 30,000 employees in 30 countries.
The company champions complex business opportunities and challenges with its world-class services in Advanced Analytics, AI, Digital Platforms, Cloud, Hyperautomation, IoT, Low-code, and so on. It has partnered with over 1,100 clients worldwide, nearly 100 of which are Fortune Global 500 companies in Aviation, Automotive, Banking, Financial Services and Insurance, Healthcare, Logistics, Manufacturing, Utilities, and more. For more information, please visit https://fptsoftware.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240804936324/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom